178 related articles for article (PubMed ID: 34511983)
1. Four Immune-Related Genes (FN1, UGCG, CHPF2 and THBS2) as Potential Diagnostic and Prognostic Biomarkers for Carbon Nanotube-Induced Mesothelioma.
Xie D; Hu J; Wu T; Cao K; Luo X
Int J Gen Med; 2021; 14():4987-5003. PubMed ID: 34511983
[TBL] [Abstract][Full Text] [Related]
2. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker.
Lin P; Zhao Y; Li X; Liang Z
Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152
[TBL] [Abstract][Full Text] [Related]
3. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
Zhang X; Yang L; Chen W; Kong M
Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
[TBL] [Abstract][Full Text] [Related]
4. Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Xie D; Luo X
Toxicol Appl Pharmacol; 2021 Feb; 412():115391. PubMed ID: 33387576
[TBL] [Abstract][Full Text] [Related]
5. Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods.
Liu X; Qian K; Lu G; Chen P; Zhang Y
BMC Med Genomics; 2021 Apr; 14(1):104. PubMed ID: 33849532
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients.
Bai Y; Wang X; Hou J; Geng L; Liang X; Ruan Z; Guo H; Nan K; Jiang L
Front Genet; 2020; 11():899. PubMed ID: 32849853
[TBL] [Abstract][Full Text] [Related]
7. Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma.
Guo Z; Shen L; Li N; Wu X; Wang C; Gu Z; Chen Z; Liu J; Mao W; Han Y
Front Oncol; 2021; 11():789244. PubMed ID: 34956905
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance and immune cell infiltration analysis of differentially expressed genes in malignant pleural mesothelioma].
Wang N; Zhao QN; Yuan Q; Zhu BL; Wu W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):641-647. PubMed ID: 37805421
[No Abstract] [Full Text] [Related]
9. Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis.
Li Z; Feng J; Zhong J; Lu M; Gao X; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():864407. PubMed ID: 35923621
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma.
Xu X; Cheng L; Fan Y; Mao W
Front Oncol; 2020; 10():544789. PubMed ID: 33042835
[TBL] [Abstract][Full Text] [Related]
11. Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning.
Xiao Y; Huang W; Zhang L; Wang H
Front Endocrinol (Lausanne); 2022; 13():1056152. PubMed ID: 36523602
[TBL] [Abstract][Full Text] [Related]
12. Identifying
Ding J; Liu Y; Lai Y
PeerJ; 2020; 8():e10419. PubMed ID: 33282565
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
14. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
[No Abstract] [Full Text] [Related]
16. Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis.
Huang S; Pang L; Wei C
Front Genet; 2021; 12():678780. PubMed ID: 34616422
[TBL] [Abstract][Full Text] [Related]
17. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
18. A network-biology approach for identification of key genes and pathways involved in malignant peritoneal mesothelioma.
Mahfuz AMUB; Zubair-Bin-Mahfuj AM; Podder DJ
Genomics Inform; 2021 Jun; 19(2):e16. PubMed ID: 34261301
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
Kim K; Ko Y; Oh H; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Heo HJ; Kim G; Kim JW; Kim YH
J Toxicol Environ Health A; 2020 Feb; 83(3):126-134. PubMed ID: 32114955
[TBL] [Abstract][Full Text] [Related]
20. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
